Analyzing The FDA Bill’s Course: Bipartisanship Or Something Else?
Politico: FDA Bill No Model For Bipartisanship
The bipartisan treatment the FDA user fee bill has enjoyed did not fall like manna from heaven. It came at the insistence of the pharmaceutical and medical device industries, the FDA and legislators on both sides of the aisle who agreed early on they would get a deal done. And then actually did it (Norman, 6/25).